BRCA1 and BRCA2 carriers with breast, ovarian and prostate cancer demonstrate a different pattern of metastatic disease compared with non‐carriers: results from a rapid autopsy pro... von Thorne, Heather, Devereux, Lisa, Li, Jason, Alsop, Kathryn, Christie, Liz, Geelen, Courtney T, Burdett, Nikki, Pishas, Kathleen I, Woodford, Noel, Leditschke, Jodie, Izzath, Mohamed H M A, Strachan, Kate, Young, Gregory, Jaravaza, Rufaro D, Madadin, Mohammed S, Archer, Melanie, Glengarry, Joanna, Iles, Linda, Rathnaweera, Ajith, Hampson, Clare, Almazrooei, Khamis, Burke, Michael, Bandara, Pradeep, Ranson, David, Saeedi, Essa, McNally, Orla, Mileshkin, Linda, Hamilton, Anne, Ananda, Sumitra, Au‐Yeung, George, Antill, Yoland, Sandhu, Shahneen, Savas, Peter, Francis, Prudence A, Luen, Stephen, Loi, Sherene, Jennens, Ross, Scott, Clare, Moodie, Kate, Cummings, Margaret, Reid, Andrew, Reed, Amy McCart, Bowtell, David, Lakhani, Sunil R, Fox, Stephen

Volltext

Clinical implications of prospective genomic profiling of metastatic breast cancer patients von van Geelen, Courtney T., Savas, Peter, Teo, Zhi Ling, Luen, Stephen J., Weng, Chen-Fang, Ko, Yi-An, Kuykhoven, Keilly S., Caramia, Franco, Salgado, Roberto, Francis, Prudence A., Dawson, Sarah-Jane, Fox, Stephen B., Fellowes, Andrew, Loi, Sherene

Volltext

Correction to: Clinical implications of prospective genomic profiling of metastatic breast cancer patients von van Geelen, Courtney T, Savas, Peter, Teo, Zhi Ling, Luen, Stephen J, Weng, Chen-Fang, Ko, Yi-An, Kuykhoven, Keilly S, Caramia, Franco, Salgado, Roberto, Francis, Prudence A, Dawson, Sarah-Jane, Fox, Stephen B, Fellowes, Andrew, Loi, Sherene

Volltext

Sustained lymphocyte decreases after treatment for early breast cancer von Dixon-Douglas, Julia, Virassamy, Balaji, Clarke, Kylie, Hun, Michael, Luen, Stephen J., Savas, Peter, van Geelen, Courtney T., David, Steven, Francis, Prudence A., Salgado, Roberto, Michiels, Stefan, Loi, Sherene

Volltext

Alpelisib Monotherapy for PI3K-Altered, Pretreated Advanced Breast Cancer: A Phase II Study von Savas, Peter, Lo, Louisa L., Luen, Stephen J., Blackley, Elizabeth F., Callahan, Jason, Moodie, Kate, van Geelen, Courtney T., Ko, Yi-An, Weng, Chen-Fang, Wein, Lironne, Silva, Maria João, Bujak, Andjelija Zivanovic, Yeung, Miriam M., Ftouni, Sarah, Hicks, Rodney J., Francis, Prudence A., Lee, Chee Khoon, Dawson, Sarah-Jane, Loi, Sherene

Volltext

Abstract P5-02-16: SPEN is a biomarker for CDK4/6 inhibitor resistance in patients with metastatic hormone receptor positive (HR+)/HER2- breast cancer von van Geelen, Courtney T., Teo, Zhi Ling, Savas, Peter, Luen, Stephen J., Clarke, Kylie A., Sant, Sneha, Cowley, Karla J., Caramia, Franco, Simpson, Kaylene J., Andre, Fabrice, Dawson, Sarah-Jane, Pearson, Richard, Loi, Sherene

Volltext

Circulating tumour DNA in metastatic breast cancer to guide clinical trial enrolment and precision oncology: A cohort study von Zivanovic Bujak, Andjelija, Weng, Chen-Fang, Silva, Maria Joao, Yeung, Miriam, Lo, Louisa, Ftouni, Sarah, Litchfield, Cassandra, Ko, Yi-An, Kuykhoven, Keilly, Van Geelen, Courtney, Chandrashekar, Sushma, Dawson, Mark A., Loi, Sherene, Wong, Stephen Q., Dawson, Sarah-Jane

Volltext

Abstract P1-18-14: Alpelisib monotherapy for PI3K-altered, pre-treated advanced breast cancer: A phase II study von Savas, Peter, Lo, Louisa Lisa, Luen, Stephen James, Blackley, Elizabeth Fay, van Geelen, Courtney Templeton, Ko, Yi-An, Moodie, Kate, Callahan, Jason William, Weng, Chen-Fang, Bujak, Andjelija Zivanovic, Yeung, Miriam Manning, Ftouni, Sarah, Francis, Prudence Anne, Dawson, Sarah-Jane, Loi, Sherene

Volltext

Circulating tumour DNA in metastatic breast cancer to guide clinical trial enrolment and precision oncology: A cohort study von Andjelija Zivanovic Bujak, Chen-Fang Weng, Maria João Silva, Miriam Yeung, Louisa Lo, Sarah Ftouni, Cassandra Litchfield, Yi-An Ko, Keilly Kuykhoven, Courtney Van Geelen, Sushma Chandrashekar, Mark A. Dawson, Sherene Loi, Stephen Q. Wong, Sarah-Jane Dawson, Charles Swanton

Volltext